| 10695350 |
Methods of treating and preventing graft versus host disease |
John C. Byrd, Jason A. Dubovsky, Amy J. Johnson, David Miklos |
2020-06-30 |
| 10463668 |
Methods of treating and preventing graft versus host disease |
John C. Byrd, Jason A. Dubovsky, Amy J. Johnson, David Miklos |
2019-11-05 |
| 10357514 |
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor |
Carl H. June, David L. Porter, Marcela Maus, Mariusz A. Wasik, Saar Gill +11 more |
2019-07-23 |
| 9795604 |
Methods of treating and preventing graft versus host disease |
John C. Byrd, Jason A. Dubovsky, Amy J. Johnson, David Miklos |
2017-10-24 |
| 9717731 |
TEC family kinase inhibitor adjuvant therapy |
Joseph J. Buggy, Tarak D. Mody, John C. Byrd, Betty Y. Chang, Jason A. Dubovsky +1 more |
2017-08-01 |
| 8633161 |
Therapeutic agents for the treatment of leukemia |
Danilo Perrotti, Paolo Neviani, Ramasamy Santhanam, John C. Byrd, Guido Marcucci +1 more |
2014-01-21 |
| 8591892 |
FTY720 increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell death |
Lapo Alinari, Robert A. Baiocchi, Hans J. Hansen, David M. Goldenberg |
2013-11-26 |
| 8318812 |
Therapeutic agents for the treatment of lymphoid malignancies |
John C. Byrd, Danilo Perrotti, Ching-Shih Chen, James T. Dalton, Frank Frissora +2 more |
2012-11-27 |
| 8309768 |
FTY720-derived anticancer agents |
Ching-Shih Chen, Samuel K. Kulp, Dasheng Wang, John C. Byrd |
2012-11-13 |